EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.57 | Carcinoma, Ehrlich Tumor |
3415705 |
Specificity of a nucleolar 2'-O-methyltransferase for RNA substrates. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 2.1.1.57 | Neoplasms |
3415705 |
Specificity of a nucleolar 2'-O-methyltransferase for RNA substrates. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 2.1.1.57 | Carcinoma, Ehrlich Tumor |
3593683 |
Isolation and characterization of a nucleolar 2'-O-methyltransferase from Ehrlich ascites tumor cells. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 2.1.1.57 | Neoplasms |
3593683 |
Isolation and characterization of a nucleolar 2'-O-methyltransferase from Ehrlich ascites tumor cells. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 2.1.1.57 | Vaccinia |
8051170 |
Mutational analysis of a multifunctional protein, with mRNA 5' cap-specific (nucleoside-2'-O-)-methyltransferase and 3'-adenylyltransferase stimulatory activities, encoded by vaccinia virus. |
causal interaction
unassigned |
1
0 |
| 2.1.1.57 | Vaccinia |
8612277 |
The 1.85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.57 | Vaccinia |
8846300 |
Methyltransferase-specific domains within VP-39, a bifunctional protein that participates in the modification of both mRNA ends. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.57 | Vaccinia |
9622508 |
Recognition of capped RNA substrates by VP39, the vaccinia virus-encoded mRNA cap-specific 2'-O-methyltransferase. |
unassigned |
0 |
| 2.1.1.57 | Vaccinia |
9917386 |
A polyadenylylation-specific RNA-contact site on the surface of the bifunctional vaccinia virus RNA modifying protein VP39 that is distinct from the mRNA 5' end-binding "cleft". |
therapeutic application
unassigned |
1
0 |
| 2.1.1.57 | Vaccinia |
10753713 |
The vaccinia virus bifunctional gene J3 (nucleoside-2'-O-)-methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches. |
diagnostic usage
therapeutic application
unassigned |
3
1
0 |
